Additionally, the inhibitory effects of ECD on FAS, SREBP-2, and HMGCS1 were attenuated upon inhibition of AMPK by CC in HepG2 NAFLD cells (Figure 5C,E–G). Here, SREBF2 is linked to metabolic dysfunction-associated steatotic liver disease.